[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP2412714A4 - Procédé de purification industrielle de phycotoxines biologiquement actives - Google Patents

Procédé de purification industrielle de phycotoxines biologiquement actives

Info

Publication number
EP2412714A4
EP2412714A4 EP20100755518 EP10755518A EP2412714A4 EP 2412714 A4 EP2412714 A4 EP 2412714A4 EP 20100755518 EP20100755518 EP 20100755518 EP 10755518 A EP10755518 A EP 10755518A EP 2412714 A4 EP2412714 A4 EP 2412714A4
Authority
EP
European Patent Office
Prior art keywords
phycotoxins
biologically active
industrial purification
purification
industrial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP20100755518
Other languages
German (de)
English (en)
Other versions
EP2412714A1 (fr
EP2412714B1 (fr
EP2412714B9 (fr
Inventor
Gonzalez Marcelo Santiago Lagos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proteus SA
Original Assignee
Proteus SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteus SA filed Critical Proteus SA
Publication of EP2412714A1 publication Critical patent/EP2412714A1/fr
Publication of EP2412714A4 publication Critical patent/EP2412714A4/fr
Publication of EP2412714B1 publication Critical patent/EP2412714B1/fr
Priority to HRP20160079TT priority Critical patent/HRP20160079T1/hr
Application granted granted Critical
Publication of EP2412714B9 publication Critical patent/EP2412714B9/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/16Peri-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cephalosporin Compounds (AREA)
EP10755518.7A 2009-03-24 2010-03-18 Procédé de purification industrielle de phycotoxines biologiquement actives Active EP2412714B9 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HRP20160079TT HRP20160079T1 (hr) 2009-03-24 2016-01-25 Postupak industrijskog pročišćavanja biološki aktivnih fikotoksina

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CL2009000723A CL2009000723A1 (es) 2009-03-24 2009-03-24 Metodo de purificacion industrial de ficotoxinas biologicamente activas que comprende proporcionar una cantidad adecuada de una fuente de ficotoxinas como por ejemplo el cultivo de un clon de cianobacterias.
PCT/IB2010/051187 WO2010109386A1 (fr) 2009-03-24 2010-03-18 Procédé de purification industrielle de phycotoxines biologiquement actives

Publications (4)

Publication Number Publication Date
EP2412714A1 EP2412714A1 (fr) 2012-02-01
EP2412714A4 true EP2412714A4 (fr) 2012-10-10
EP2412714B1 EP2412714B1 (fr) 2015-11-11
EP2412714B9 EP2412714B9 (fr) 2016-11-23

Family

ID=42780210

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10755518.7A Active EP2412714B9 (fr) 2009-03-24 2010-03-18 Procédé de purification industrielle de phycotoxines biologiquement actives

Country Status (14)

Country Link
EP (1) EP2412714B9 (fr)
JP (1) JP5728774B2 (fr)
KR (1) KR20110130420A (fr)
AR (1) AR075931A1 (fr)
BR (1) BRPI1013548B8 (fr)
CA (1) CA2754154C (fr)
CL (1) CL2009000723A1 (fr)
DK (1) DK2412714T5 (fr)
ES (1) ES2562637T3 (fr)
HR (1) HRP20160079T1 (fr)
HU (1) HUE027480T2 (fr)
MX (1) MX2011010005A (fr)
PE (1) PE20110903A1 (fr)
WO (1) WO2010109386A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8957207B2 (en) 2009-03-24 2015-02-17 Proteus S.A. Methods for producing phycotoxins
EP2968225B1 (fr) 2013-03-15 2019-02-20 The Children's Medical Center Corporation Formulations combinées de néosaxitoxine pour une anesthésie locale prolongée
US9902625B2 (en) 2014-09-03 2018-02-27 International Business Machines Corporation Removal of HAB-produced toxins from bodies of water
GB201602576D0 (en) 2016-02-12 2016-03-30 Bergen Teknologioverforing As Process
CN107602580B (zh) * 2017-09-08 2019-06-11 浙江理工大学 一种聚酮类化合物及其制备方法和应用
CN109142595A (zh) * 2018-08-23 2019-01-04 中国水产科学研究院黄海水产研究所 一种麻痹性贝类毒素标准溶液的制备方法
US12018034B2 (en) 2018-09-21 2024-06-25 The Cawthron Institute Trust Board Semisynthetic methods of preparing GTX1,4 and neosaxitoxin
CN117964629A (zh) * 2018-09-21 2024-05-03 考思隆研究所托管委员会 将膝沟藻毒素制备性规模转化为新石房蛤毒素
WO2020058750A1 (fr) * 2018-09-21 2020-03-26 The Cawthron Institute Trust Board Procédé semi-synthétique de préparation de néosaxitoxine
CN114657222A (zh) * 2022-04-08 2022-06-24 湖北省水利水电科学研究院 一种从水华束丝藻中提取类菌胞素氨基酸的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080006579A1 (en) * 2006-06-21 2008-01-10 Degussa Gmbh Processing of reaction solutions from whole-cell biotransformations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001413A (en) 1973-06-12 1977-01-04 Astra Pharmaceutical Products, Inc. Pharmaceutical local anesthetic composition employing saxitoxin
WO1998043619A2 (fr) * 1997-04-02 1998-10-08 The Regents Of The University Of California Procede d'anesthesie
KR20040066816A (ko) * 2001-11-15 2004-07-27 마이크로 알제 코포레이션 3, 4-프로피온퍼하이드로퓨린을 포함하는 약학 조성물 및상기 조성물을 이용한 신경 전달의 블로킹 방법
EP1824488B1 (fr) * 2004-05-07 2017-08-09 Algenis SpA Les phycotoxines et leur utilisation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080006579A1 (en) * 2006-06-21 2008-01-10 Degussa Gmbh Processing of reaction solutions from whole-cell biotransformations

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
EDWARD J. SCHANTZ ET AL: "The Purification and Characterization of the Poison Produced by Gonyaulax catenella in Axenic Culture", BIOCHEMISTRY, vol. 5, no. 4, 1 April 1966 (1966-04-01), pages 1191 - 1195, XP055036404, ISSN: 0006-2960, DOI: 10.1021/bi00868a011 *
GHAZAROSSIAN V E ET AL: "Identification of a poison in toxic scallops from a Gonyaulax tamarensis red tide", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 59, no. 4, 19 August 1974 (1974-08-19), pages 1219 - 1225, XP024777990, ISSN: 0006-291X, [retrieved on 19740819], DOI: 10.1016/0006-291X(74)90444-6 *
IL SHIK SHIN ET AL: "Reestablishment of Approval Toxin Amount in Paralytic Shellfish Poison-Infested Shellfish", J. FD HYG. SAFETY, 31 December 1998 (1998-12-31), pages 143 - 148, XP055036412, Retrieved from the Internet <URL:http://210.101.116.28/W_ftp41/14600812_pv.pdf> [retrieved on 20120827] *
LUBNA ZAMAN ET AL: "Occurrence of paralytic shellfish poison in Bangladeshi freshwater puffers", TOXICON, vol. 35, no. 3, 1 March 1997 (1997-03-01), pages 423 - 431, XP055036381, ISSN: 0041-0101, DOI: 10.1016/S0041-0101(96)00167-5 *
See also references of WO2010109386A1 *

Also Published As

Publication number Publication date
BRPI1013548A2 (pt) 2016-09-20
ES2562637T9 (es) 2017-05-30
CA2754154C (fr) 2013-12-17
PE20110903A1 (es) 2012-01-19
EP2412714A1 (fr) 2012-02-01
AR075931A1 (es) 2011-05-04
CA2754154A1 (fr) 2010-09-30
BRPI1013548B8 (pt) 2021-05-25
HRP20160079T1 (hr) 2016-04-08
KR20110130420A (ko) 2011-12-05
HUE027480T2 (en) 2016-09-28
EP2412714B1 (fr) 2015-11-11
DK2412714T3 (en) 2016-02-01
CL2009000723A1 (es) 2009-06-19
DK2412714T5 (en) 2017-02-27
MX2011010005A (es) 2011-10-10
WO2010109386A1 (fr) 2010-09-30
BRPI1013548B1 (pt) 2020-06-09
JP5728774B2 (ja) 2015-06-03
ES2562637T3 (es) 2016-03-07
JP2012521408A (ja) 2012-09-13
EP2412714B9 (fr) 2016-11-23

Similar Documents

Publication Publication Date Title
EP2412714A4 (fr) Procédé de purification industrielle de phycotoxines biologiquement actives
HK1173716A1 (en) Method for the biological purification of ammonium-containing wastewater
SI2398785T1 (sl) Äśiĺ äśenje 1-(2-(2,4-dimetilfenilsulfanil)fenil)-piperazina
PL3715356T3 (pl) Sposób oczyszczania polipeptydów
HRP20150761T1 (hr) Postupak za proäśišä†avanje lipopeptida
SI2504334T1 (sl) Postopek čiščenja (4,6-diamino-2-(1-(2-fluorobenzil)-1H-pirazolo-(3,4-b)piridin-3-il)piri midin-5-il)metilkarbamata
EP2613857A4 (fr) Procédé de purification d&#39;immunoconjugués ou de polypeptides actifs
LT2504350T (lt) Glikoproteinų gryninimo būdas
IL243248A0 (en) Purification method
GB0922623D0 (en) Methods for the purification of cucurbituril
ZA201104266B (en) Multifraction purification processes and devices for such processes
GB0808908D0 (en) Purification process
GB2506955B (en) Bioreactor for the treatment of industrial waste
ZA201300320B (en) Purification process
EP2516412A4 (fr) Procédés de purification du lubiprostone
ZA201200420B (en) Method for the purification of protein complexes
GB0818228D0 (en) Purification process
IL214740A0 (en) Process for the purification of amorolfine hydrochloride
GB2459738B (en) Method of purification
EP2479147A4 (fr) Procédé de purification biologique d&#39;eaux usées
PT3640218T (pt) Processo de tratamento de resíduos industriais
GB0811505D0 (en) Purification process
EP2454202A4 (fr) Procédé de purification biologique
EP2412695A4 (fr) Procédé de purification du dihydroxybenzène
AU2009902254A0 (en) Salt purification process

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110720

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120906

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 21/02 20060101ALI20120831BHEP

Ipc: A61K 31/519 20060101ALI20120831BHEP

Ipc: A61P 23/02 20060101ALI20120831BHEP

Ipc: C07D 471/16 20060101AFI20120831BHEP

17Q First examination report despatched

Effective date: 20131106

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20150602

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 760381

Country of ref document: AT

Kind code of ref document: T

Effective date: 20151215

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602010029015

Country of ref document: DE

REG Reference to a national code

Ref country code: HR

Ref legal event code: TUEP

Ref document number: P20160079

Country of ref document: HR

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20160129

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: FIAMMENGHI-FIAMMENGHI, CH

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2562637

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20160307

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 7

REG Reference to a national code

Ref country code: PT

Ref legal event code: SC4A

Free format text: AVAILABILITY OF NATIONAL TRANSLATION

Effective date: 20160210

REG Reference to a national code

Ref country code: HR

Ref legal event code: T1PR

Ref document number: P20160079

Country of ref document: HR

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 760381

Country of ref document: AT

Kind code of ref document: T

Effective date: 20151111

Ref country code: EE

Ref legal event code: FG4A

Ref document number: E011634

Country of ref document: EE

Effective date: 20160202

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160211

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160311

GRAT Correction requested after decision to grant or after decision to maintain patent in amended form

Free format text: ORIGINAL CODE: EPIDOSNCDEC

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151111

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151111

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160212

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151111

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602010029015

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151111

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151111

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151111

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

GRAE Information related to correction after decision to grant or after decision to maintain patent in amended form modified

Free format text: ORIGINAL CODE: EPIDOSCCDEC

REG Reference to a national code

Ref country code: HU

Ref legal event code: AG4A

Ref document number: E027480

Country of ref document: HU

26N No opposition filed

Effective date: 20160812

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151111

REG Reference to a national code

Ref country code: EE

Ref legal event code: LD4A

Ref document number: E011634

Country of ref document: EE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151111

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

REG Reference to a national code

Ref country code: DK

Ref legal event code: T5

Effective date: 20170220

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151111

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160331

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151111

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151111

REG Reference to a national code

Ref country code: HR

Ref legal event code: ODRP

Ref document number: P20160079

Country of ref document: HR

Payment date: 20190228

Year of fee payment: 10

REG Reference to a national code

Ref country code: HR

Ref legal event code: ODRP

Ref document number: P20160079

Country of ref document: HR

Payment date: 20200317

Year of fee payment: 11

REG Reference to a national code

Ref country code: HR

Ref legal event code: ODRP

Ref document number: P20160079

Country of ref document: HR

Payment date: 20210312

Year of fee payment: 12

REG Reference to a national code

Ref country code: HR

Ref legal event code: ODRP

Ref document number: P20160079

Country of ref document: HR

Payment date: 20220317

Year of fee payment: 13

REG Reference to a national code

Ref country code: HR

Ref legal event code: ODRP

Ref document number: P20160079

Country of ref document: HR

Payment date: 20230322

Year of fee payment: 14

REG Reference to a national code

Ref country code: HR

Ref legal event code: ODRP

Ref document number: P20160079

Country of ref document: HR

Payment date: 20240318

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LT

Payment date: 20240318

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20240326

Year of fee payment: 15

Ref country code: LU

Payment date: 20240327

Year of fee payment: 15

Ref country code: NL

Payment date: 20240318

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FI

Payment date: 20240326

Year of fee payment: 15

Ref country code: EE

Payment date: 20240319

Year of fee payment: 15

Ref country code: DE

Payment date: 20240318

Year of fee payment: 15

Ref country code: GB

Payment date: 20240318

Year of fee payment: 15

Ref country code: PT

Payment date: 20240318

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20240328

Year of fee payment: 15

Ref country code: LV

Payment date: 20240318

Year of fee payment: 15

Ref country code: IT

Payment date: 20240318

Year of fee payment: 15

Ref country code: HR

Payment date: 20240318

Year of fee payment: 15

Ref country code: FR

Payment date: 20240327

Year of fee payment: 15

Ref country code: DK

Payment date: 20240318

Year of fee payment: 15

Ref country code: BE

Payment date: 20240326

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20240401

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20240404

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: HU

Payment date: 20240417

Year of fee payment: 15